GO:1905590 fibronectin fibril organization: Matrix Assembly Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905590 fibronectin fibril organization describes the cellular process that assembles, arranges, or disassembles fibronectin fibrils, a key step in extracellular matrix (ECM) formation.
• Fibronectin fibril assembly is a cell-driven process requiring integrin binding, fibronectin conformational activation, and fibrillar elongation at the cell surface.
• The process is essential for tissue architecture, wound healing, and embryonic development, and its dysregulation contributes to fibrosis, cancer progression, and glaucoma.
• Key molecular players include FN1 (fibronectin), integrins such as α5β1 and αvβ3, and extracellular chaperones like ERp57 that promote fibril formation.
• Experimental models for studying fibronectin fibril organization include knockout and knock-in cell lines, tagged fibronectin reporters, and CRISPR-based screens.
• Modulating fibronectin ECM can enhance anti-tumor efficacy of immune checkpoint blockade, highlighting therapeutic relevance.
Description
Fibronectin fibril organization (GO:1905590) is the biological process that governs the assembly, arrangement, and disassembly of fibronectin fibrils, which are supramolecular ECM structures critical for tissue integrity and cell signaling. Fibronectin is a large multidomain glycoprotein that circulates in plasma and is also secreted locally by many cell types; its assembly into insoluble fibrils is a cell-mediated process that converts soluble dimers into an extended, fibrillar network. This process is not merely structural: fibronectin fibrils serve as a scaffold for other ECM components, regulate cell adhesion, migration, proliferation, and differentiation, and are dynamically remodeled during development, wound healing, and disease. Researchers study fibronectin fibril organization to understand fundamental ECM biology and to target pathological matrix remodeling in cancer, fibrosis, and ocular disorders such as primary open angle glaucoma. The QuickGO definition emphasizes that this process occurs at the cellular level and encompasses both assembly and disassembly, reflecting the dynamic nature of the fibronectin matrix.
fibronectin fibril organization At A Glance
| GO ID | GO:1905590 |
|---|---|
| GO term | fibronectin fibril organization |
| Ontology | biological_process |
| Synonym | none |
| Major function | Assembly, arrangement, and disassembly of fibronectin fibrils in the extracellular matrix |
| Cellular location | Extracellular matrix; cell surface; fibrillar adhesions |
| Key molecules | Fibronectin (FN1), integrins (α5β1, αvβ3), ERp57, and associated ECM proteins |
| Related processes | ECM organization, cell adhesion, wound healing, tissue remodeling |
| Disease relevance | Cancer, fibrosis, glaucoma, and other matrix-related pathologies |
What Is GO:1905590?
GO:1905590 fibronectin fibril organization is defined by QuickGO as a process carried out at the cellular level that results in the assembly, arrangement of constituent parts, or disassembly of a fibronectin fibril. In other words, it covers all cellular activities that build, organize, or break down fibronectin-containing fibrils, which are key structural and signaling components of the extracellular matrix.
Why Is fibronectin fibril organization Important in Cell Biology?
Fibronectin fibril organization is fundamental to tissue architecture and cell behavior because fibronectin fibrils provide a provisional matrix that directs cell adhesion, migration, and differentiation, and serves as a template for collagen deposition. Dysregulated fibronectin assembly is a hallmark of many diseases, including cancer, where it promotes tumor progression and immune evasion, and fibrosis, where excessive matrix deposition impairs organ function. Understanding this process at the molecular level is therefore essential for developing therapies that target the ECM.
• Provides structural support and signaling cues for cell adhesion, migration, and differentiation.
• Serves as a scaffold for collagen and other ECM proteins during tissue remodeling.
• Critical for embryonic development and wound healing.
• Dysregulated in cancer, where fibronectin matrix promotes tumor growth and immune suppression.
• Implicated in primary open angle glaucoma through altered trabecular meshwork ECM.
• Modulating fibronectin ECM can enhance anti-tumor efficacy of immune checkpoint blockade.
• Extracellular chaperone ERp57 promotes fibronectin fibril formation in articular cartilage.
• Fibronectin fibril organization is a target for anti-fibrotic and anti-cancer strategies.
• Dynamic remodeling of fibronectin fibrils is essential for tissue homeostasis.
• Research tools such as CRISPR knockouts enable causal dissection of this process.
What Happens During fibronectin fibril organization?
Initiation: Fibronectin Activation and Integrin Binding
In simple terms: Fibronectin molecules are activated and grabbed by integrins on the cell surface.
Fibronectin fibril assembly begins when soluble fibronectin dimers bind to integrin receptors such as α5β1 and αvβ3 on the cell surface. This binding triggers conformational changes in fibronectin that expose cryptic self-association sites, a process known as fibronectin activation. The interaction between fibronectin and integrins is essential for initiating fibril formation, and without it, fibronectin remains in a soluble, non-fibrillar form.
Elongation and Fibril Assembly
In simple terms: Fibronectin molecules are stretched and linked together into long fibrils.
Following activation, fibronectin molecules are stretched by cell-generated tension, which unfolds domains and allows intermolecular interactions that drive fibril elongation. This step requires actin cytoskeleton contractility and is regulated by integrin clustering and signaling. The resulting fibrils are insoluble and can be further stabilized by cross-linking.
Maturation and ECM Scaffolding
In simple terms: The fibrils mature and serve as a scaffold for other matrix proteins.
As fibrils elongate, they form a dense network that serves as a scaffold for collagen and other ECM components, directing tissue architecture. Maturation involves fibril bundling and association with other matrix proteins, and is influenced by cellular signals and extracellular chaperones such as ERp57. This mature matrix provides mechanical support and biochemical cues to cells.
Disassembly and Remodeling
In simple terms: Fibrils can be broken down and reorganized when tissues remodel.
Fibronectin fibrils are not static; they undergo disassembly and remodeling during processes such as wound healing, development, and disease progression. Disassembly can be mediated by proteases, changes in integrin engagement, or cellular tension, allowing dynamic turnover of the ECM. This remodeling is critical for tissue homeostasis and is dysregulated in pathological conditions.
Key Genes Involved in GO:1905590 fibronectin fibril organization
The following genes and proteins are central to fibronectin fibril organization, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FN1 | Encodes fibronectin, the primary component of fibrils | Core structural protein; knockout and tagged knock-in models |
| ITGA5 | Integrin α5 subunit; binds fibronectin to initiate assembly | Knockout reduces fibril formation; target for ECM studies |
| ITGB1 | Integrin β1 subunit; partners with α5 for fibronectin binding | Essential for fibril assembly; conditional KO models |
| ITGAV | Integrin αv subunit; alternative fibronectin receptor | Modulates fibril organization in cancer and fibrosis |
| ITGB3 | Integrin β3 subunit; forms αvβ3 with ITGAV | Involved in fibronectin matrix in angiogenesis |
| ERp57 (PDIA3) | Extracellular chaperone promoting fibronectin fibril formation | Knockdown reduces fibril assembly in cartilage |
| COL1A1 | Collagen I; co-assembles with fibronectin fibrils | Knockout affects matrix architecture |
| COL1A2 | Collagen I alpha 2; co-assembles with fibronectin | Relevant for tissue-specific matrix |
| FN1-EGFP | Tagged fibronectin reporter | Live imaging of fibril assembly |
| LOX | Lysyl oxidase; cross-links ECM proteins | Modulates fibril stability |
| TGFB1 | Cytokine inducing fibronectin expression | Regulates fibril organization in fibrosis |
| MMP2 | Matrix metalloproteinase; degrades fibronectin | Involved in fibril disassembly |
| MMP9 | Matrix metalloproteinase; degrades fibronectin | Remodeling in cancer and inflammation |
| RAC1 | Small GTPase regulating actin cytoskeleton | Affects fibronectin fibril assembly |
| RHOA | Small GTPase controlling contractility | Modulates fibril elongation |
| PTK2 (FAK) | Focal adhesion kinase; signals from integrins | Regulates fibril assembly |
| ACTN1 | Actinin; actin cross-linker | Supports cytoskeletal tension for fibrillogenesis |
| VCL | Vinculin; links integrins to actin | Required for fibronectin fibril formation |
How Is fibronectin fibril organization Regulated?
Fibronectin fibril organization is regulated at multiple levels. Extracellularly, ERp57 promotes fibronectin fibril formation during matrix assembly in articular cartilage. Integrin signaling through focal adhesion kinase (FAK) and small GTPases such as RhoA and Rac1 controls cytoskeletal tension necessary for fibril elongation. Growth factors like TGF-β1 induce fibronectin expression and modulate assembly. Proteases such as MMP2 and MMP9 mediate disassembly and remodeling. Additionally, the composition of the ECM, including collagen co-assembly, influences fibril organization.
fibronectin fibril organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FN1 | Cancer, fibrosis, glaucoma | FN1 knockout and knock-in cell lines |
| ITGA5 | Cancer, fibrosis | ITGA5 knockout cells to block fibril assembly |
| ERp57 (PDIA3) | Arthritis, cartilage degeneration | PDIA3 knockdown in chondrocytes |
| TGFB1 | Fibrosis | TGFB1 overexpression or knockout in fibroblasts |
| MMP2 | Cancer invasion | MMP2 knockout to study fibril disassembly |
Fibronectin Fibril Organization in Cancer
In cancer, fibronectin fibril organization contributes to tumor progression by promoting cell proliferation, migration, and immune evasion. Modulation of fibronectin ECM enhances anti-tumor efficacy of immune checkpoint blockade, suggesting that targeting fibril assembly could improve immunotherapy outcomes. Fibronectin fibrils also serve as tracks for cancer cell invasion and metastasis.
Fibronectin Fibril Organization in Glaucoma
Primary open angle glaucoma is associated with altered fibronectin levels and fibril organization in the trabecular meshwork, leading to increased aqueous humor outflow resistance. Fibronectin plays a role in the pathogenesis of this disease, and targeting its assembly may offer therapeutic avenues.
Fibronectin Fibril Organization in Cartilage and Arthritis
Extracellular ERp57 promotes fibronectin fibril formation during matrix assembly of articular cartilage, and dysregulation of this process may contribute to cartilage degeneration in arthritis. Proper fibronectin fibril organization is essential for cartilage integrity.
Fibronectin Fibril Organization in Fibrosis
Excessive fibronectin fibril assembly is a hallmark of fibrosis in organs such as lung, liver, and kidney. TGF-β1-induced fibronectin expression and assembly drive fibrotic remodeling, making this process a target for anti-fibrotic therapies.
From fibronectin fibril organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FN1 knockout abolish fibronectin fibril organization? | FN1 knockout cell line (e.g., CRISPR-Cas9) |
| How does a point mutation in FN1 affect fibril assembly? | FN1 point-mutation knock-in cells |
| Can tagged fibronectin be used to visualize fibrils? | FN1-EGFP knock-in reporter cells |
| Does ERp57 promote fibronectin fibril formation? | PDIA3 knockdown or knockout in cartilage cells |
| Does overexpression of TGFB1 increase fibril assembly? | TGFB1 overexpression in fibroblasts |
| Can modulation of fibronectin ECM enhance immunotherapy? | Tumor models with fibronectin matrix modulation |
How to Study the fibronectin fibril organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Immunofluorescence | Fibrillar fibronectin structures | Visualizing fibril organization in cells |
| Detergent-insoluble fibronectin assay | Assembled vs. soluble fibronectin | Quantifying fibril assembly |
| Live-cell imaging | Dynamics of fibril assembly | Real-time monitoring with tagged fibronectin |
| CRISPR knockout screen | Genes required for fibril organization | Identifying novel regulators |
| Proteomics | Protein composition of fibrils | Discovering co-assembling proteins |
| Co-immunoprecipitation | Protein-protein interactions | Confirming fibronectin-integrin binding |
| qPCR/Western blot | Expression of fibronectin and regulators | Assessing gene expression changes |
| Atomic force microscopy | Mechanical properties of fibrils | Measuring fibril stiffness |
Imaging Fibronectin Fibrils
Fluorescence microscopy with labeled fibronectin or FN1-EGFP knock-in reporters allows real-time visualization of fibril assembly and organization. Immunostaining for fibronectin and integrins can reveal fibrillar structures in fixed cells and tissues.
Biochemical Assays for Fibril Assembly
Detergent-insoluble fibronectin fractions can be isolated to quantify assembled fibrils by immunoblotting. This method distinguishes soluble from assembled fibronectin and is useful for assessing the effects of gene knockouts or inhibitors.
CRISPR Screens for Regulators
Genome-wide CRISPR knockout screens can identify genes required for fibronectin fibril organization. Cells are selected for loss of fibrillar fibronectin, and enriched sgRNAs are sequenced to pinpoint regulators.
Proteomics and Interaction Studies
Mass spectrometry-based proteomics can identify proteins co-assembling with fibronectin fibrils, such as collagens and ERp57. Co-immunoprecipitation and proximity ligation assays can confirm interactions.
How CRISPR Can Be Used to Study GO:1905590 fibronectin fibril organization
Knockout
CRISPR knockout of FN1, ITGA5, or ITGB1 abolishes fibronectin fibril assembly, providing causal evidence for their essential roles. Knockout of ERp57 (PDIA3) reduces fibril formation in cartilage, demonstrating its importance.
Point Mutation
Point mutations in FN1 can be introduced to dissect domain-specific functions, such as the RGD sequence or synergy site, and their impact on fibril assembly. Such models help map structure-function relationships.
Knock-in
Knock-in of tagged fibronectin (e.g., FN1-EGFP) enables live imaging of fibril dynamics without altering function. Knock-in of disease-associated mutations can model pathological fibril organization.
Overexpression
Overexpression of fibronectin or TGF-β1 increases fibril assembly and can model fibrosis or cancer-associated matrix remodeling. Overexpression of MMPs promotes disassembly and invasion.
How EDITGENE Supports fibronectin fibril organization Research
Researchers studying fibronectin fibril organization-related genes often need to determine whether a candidate gene is causally involved in fibril assembly, how specific mutations affect function, or whether overexpression drives pathological matrix remodeling. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for fibronectin fibril organization research.
Frequently Asked Questions About fibronectin fibril organization
What is fibronectin fibril organization (GO:1905590)?
It is the cellular process that assembles, arranges, or disassembles fibronectin fibrils, a key step in extracellular matrix formation.
What genes are involved in fibronectin fibril organization?
Key genes include FN1, ITGA5, ITGB1, ITGAV, ITGB3, and PDIA3 (ERp57), among others.
How is fibronectin fibril assembly initiated?
It begins when soluble fibronectin binds to integrins like α5β1, triggering conformational activation and self-association.
What role does ERp57 play in fibronectin fibril organization?
Extracellular ERp57 promotes fibronectin fibril formation during matrix assembly of articular cartilage.
Can fibronectin fibril organization be studied with CRISPR?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect gene function in this process.
What diseases are linked to fibronectin fibril organization?
Cancer, fibrosis, primary open angle glaucoma, and arthritis are associated with dysregulated fibronectin assembly.
How does fibronectin fibril organization affect cancer immunotherapy?
Modulation of fibronectin ECM enhances anti-tumor efficacy of immune checkpoint blockade.
What methods are used to study fibronectin fibrils?
Immunofluorescence, detergent-insoluble assays, live-cell imaging, and CRISPR screens are common methods.
Is fibronectin fibril organization reversible?
Yes, fibrils undergo disassembly and remodeling during tissue turnover and disease.
What is the GO ID for fibronectin fibril organization?
The GO ID is GO:1905590.
Conclusion
Fibronectin fibril organization (GO:1905590) is a dynamic cellular process essential for ECM assembly, tissue architecture, and cell signaling. Its dysregulation contributes to cancer, fibrosis, glaucoma, and arthritis, making it a compelling target for therapeutic intervention. Advances in CRISPR-based models and imaging techniques continue to unravel the molecular players and regulatory mechanisms, offering new opportunities for drug discovery and personalized medicine.
References
- 1. Rellmann Y et al.. 2025. Extracellular ERp57 promotes fibronectin fibril formation during matrix assembly of articular cartilage.. iScience 28(12):114046 PMID: 41399493
- 2. Khan KA et al.. 2025. Modulation of fibronectin extracellular matrix enhances anti-tumor efficacy of immune checkpoint blockade.. Cell Rep Med 6(9):102322 PMID: 40925374
- 3. Maurer LM et al.. 2015. Dynamic structure of plasma fibronectin.. Crit Rev Biochem Mol Biol 51(4):213-27 PMID: 27185500
- 4. Sun Y et al.. 2025. Fibronectin matrix assembly at a glance.. J Cell Sci 138(6) PMID: 40130407
- 5. Faralli JA et al.. 2019. Role of Fibronectin in Primary Open Angle Glaucoma.. Cells 8(12) PMID: 31779192
- 6. Singh P et al.. 2010. Assembly of fibronectin extracellular matrix.. Annu Rev Cell Dev Biol 26:397-419 PMID: 20690820
- 8. Sevilla CA et al.. 2013. Regional fibronectin and collagen fibril co-assembly directs cell proliferation and microtissue morphology.. PLoS One 8(10):e77316 PMID: 24116223
